Resultats de la cerca - David C. Smith

Refinar resultats
  1. 1
    Small-molecule SMAC mimetics as new cancer therapeutics

    Small-molecule SMAC mimetics as new cancer therapeutics per Longchuan Bai, David C. Smith, Shaomeng Wang

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The effect of mannitol on renal function following cardio‐pulmonary bypass in patients with normal pre‐operative creatinine*

    The effect of mannitol on renal function following cardio‐pulmonary bypass in patients with normal pre‐operative creatinine* per KatherineG Yallop, S. V. Sheppard, David C Smith

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Complex refractive index spectra of whole blood and aqueous solutions of anticoagulants, analgesics and buffers in the mid-infrared

    Complex refractive index spectra of whole blood and aqueous solutions of anticoagulants, analgesics and buffers in the mid-infrared per David J. Rowe, David C. Smith, James S. Wilkinson

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction*

    The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction* per M Smith, Derek Best, S. V. Sheppard, David C Smith

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Immunological Cross-Reactivity and Neutralisation of European Viper Venoms with the Monospecific Vipera berus Antivenom ViperaTAb

    Immunological Cross-Reactivity and Neutralisation of European Viper Venoms with the Monospecific Vipera berus Antivenom ViperaTAb per Nicholas R. Casewell, Ibrahim Al‐Abdulla, David C. Smith, Ruth Coxon, J. Landon

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability

    Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability per R E Leake, L Laing, Kenneth C. Calman, Fergus Macbeth, D. Crawford, David C. Smith

    Publicat 1981
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer

    Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer per Jennifer L. Osborn, Gary G. Schwartz, David C. Smith, Robert Bahnson, Roger Day, Donald L. Trump

    Publicat 1995
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial

    Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial per Elizabeth C. Kent, Howard M. Sandler, James E. Montie, Cheryl Lee, Joseph M. Herman, Peg Esper, Judith Fardig, David C. Smith

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Enhancement of 1,25-Dihydroxyvitamin D3-Mediated Antitumor Activity With Dexamethasone

    Enhancement of 1,25-Dihydroxyvitamin D3-Mediated Antitumor Activity With Dexamethasone per Wei-bong Yu, Mariann C. McElwain, Ruth A. Modzelewski, Derick M. Russell, David C. Smith, Donald L. Trump, Candace S. Johnson

    Publicat 1998
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours

    Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours per Patrick Schöffski, Michael S. Gordon, David C. Smith, Razelle Kurzrock, Adil Daud, Nicholas J. Vogelzang, Yihua Lee, Christian Scheffold, Geoffrey I. Shapiro

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate Cancer

    Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate Cancer per Molly Kozminsky, Shamileh Fouladdel, Jae‐Seung Chung, Yugang Wang, David C. Smith, Ajjai Alva, Ebrahim Azizi, Todd M. Morgan, Sunitha Nagrath

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Psychological support for patients undergoing breast cancer surgery: a randomised study

    Psychological support for patients undergoing breast cancer surgery: a randomised study per J. M C McArdle, W D George, C S McArdle, David C. Smith, Rob Moodie, A.V.M. Hughson, Gordon Murray

    Publicat 1996
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219)

    A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219) per Ralph W. deVere White, Primo N. Lara, Bryan Goldman, Cathy Tangen, David C. Smith, David P. Wood, Maha Hussain, E. David Crawford

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Cerebral oxygenation during paediatric cardiac surgery: identification of vulnerable periods using near infrared spectroscopy

    Cerebral oxygenation during paediatric cardiac surgery: identification of vulnerable periods using near infrared spectroscopy per Piers E.F. Daubeney, David C Smith, S N Pilkington, Robert K. Lamb, James L. Monro, VT Tsang, S.A. Livesey, Steven A. Webber

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies

    FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies per Vivek Subbiah, Nicholas Iannotti, Martin Gutierrez, David C. Smith, Luis Féliz, Christine Lihou, Chuan Tian, Ian M. Silverman, Tao Ji, Mansoor N. Saleh

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

    A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors per David C. Smith, Rashmi Chugh, Amita Patnaik, Kyriakos P. Papadopoulos, Min Wang, Ann M. Kapoun, Lu Xu, Jakob Dupont, Robert Stagg, Anthony W. Tolcher

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Randomized clinical trial of a family intervention for prostate cancer patients and their spouses

    Randomized clinical trial of a family intervention for prostate cancer patients and their spouses per Laurel Northouse, Darlene Mood, Ann Schafenacker, James E. Montie, Howard M. Sandler, Jeffrey D. Forman, Maha Hussain, Kenneth J. Pienta, David C. Smith, Trace Kershaw

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer

    Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer per Celestia S. Higano, John M. Corman, David C. Smith, Arthur S. Centeno, Christopher P. Steidle, Marc Gittleman, Jonathan W. Simons, Natalie Sacks, Junko Aimi, Eric J. Small

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)

    Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) per Deborah Bradley, Dana E. Rathkopf, Rodney L. Dunn, Walter M. Stadler, Glenn Liu, David C. Smith, Роберто Пили, James A. Zwiebel, Howard I. Scher, Maha Hussain

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors

    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors per David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: